<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9215429</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2408</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mutat.</journal-id>
<journal-title-group>
<journal-title>Human mutation</journal-title>
</journal-title-group>
<issn pub-type="ppub">1059-7794</issn>
<issn pub-type="epub">1098-1004</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27860035</article-id>
<article-id pub-id-type="pmc">5865588</article-id>
<article-id pub-id-type="doi">10.1002/humu.23147</article-id>
<article-id pub-id-type="manuscript">NIHMS950172</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A cell type-specific expression signature predicts haploinsufficient
autism-susceptibility genes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Chaolin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Yufeng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Systems Biology, Columbia University, New York NY
10032, USA</aff>
<aff id="A2">
<label>2</label>Department of Biochemistry and Molecular Biophysics, Columbia
University, New York NY 10032, USA</aff>
<aff id="A3">
<label>3</label>Center for Motor Neuron Biology and Disease, Columbia University,
New York NY 10032, USA</aff>
<aff id="A4">
<label>4</label>Department of Biomedical Informatics, Columbia University, New York
NY 10032, USA</aff>
<aff id="A5">
<label>5</label>JP Sulzberger Genome Center, Columbia University, New York NY 10032,
USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be addressed:
<email>cz2294@columbia.edu</email> (C.Z.);
<email>ys2411@cumc.columbia.edu</email> (Y.S.)</corresp>
<fn fn-type="equal" id="FN2">
<label>6</label>
<p>Equal contribution</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>38</volume>
<issue>2</issue>
<fpage>204</fpage>
<lpage>215</lpage>
<!--elocation-id from pubmed: 10.1002/humu.23147-->
<abstract>
<p id="P1">Recent studies have identified many genes with rare de novo mutations in
autism, but a limited number of these have been conclusively established as
disease-susceptibility genes due to lack of recurrence and confounding
background mutations. Such extreme genetic heterogeneity severely limits
recurrenceâ€“based statistical power even in studies with a large sample
size. Here we use cell-type specific expression profiles to differentiate
mutations in autism patients from those in unaffected siblings. We report a gene
expression signature in different neuronal cell types shared by genes with
likely gene disrupting (LGD) mutations in autism cases. The signature reflects
haploinsufficiency of risk genes enriched in transcriptional and
post-transcriptional regulators, with the strongest positive associations with
specific types of neurons in different brain regions, including cortical
neurons, cerebellar granule cells, and striatal medium spiny neurons. When used
to prioritize genes with a single LGD mutation in cases, a D-score derived from
the signature achieved a precision of 40% as compared to the 15%
baseline with a minimal loss in sensitivity. An ensemble model combining D-score
with mutation intolerance metrics from Exome Aggregation Consortium further
improved the precision to 60%, resulting in 117 high-priority
candidates. These prioritized lists can facilitate identification of additional
autism-susceptibility genes.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorders</kwd>
<kwd>autism-susceptibility genes</kwd>
<kwd><italic>de novo</italic> mutations</kwd>
<kwd>cell type-specific expression signature</kwd>
<kwd>D-score</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>